LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT)

Historical Holders from Q1 2014 to Q3 2025

Symbol
LMAT on Nasdaq
Type / Class
Equity / Common Stock, $0.01 Par Value
Shares outstanding
22,672,988
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
20,971,430
Holdings value
$1,835,151,298
% of all portfolios
0.004%
Number of holders
294
Number of buys
145
Number of sells
-128
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13.8% -21.2% $287,330,114 -$75,053,782 3,102,917 -20.7% BlackRock, Inc. 31 Mar 2025
Conestoga Capital Advisors, LLC 8.12% $169,062,042 1,825,724 Conestoga Capital Advisors 31 Dec 2024
LeMaitre George W 7.43% -11.9% $147,419,609 -$21,118,438 1,684,603 -12.5% George W. LeMaitre 30 Sep 2025
Copeland Capital Management, LLC 5.21% $91,579,548 988,980 Copeland Capital Management 31 Dec 2024

Institutional Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 20,971,430 $1,835,151,298 -$6,566,670 $87.51 294
2025 Q2 21,166,185 $1,758,234,218 +$2,582,636 $83.05 283
2025 Q1 21,153,493 $1,775,213,757 -$3,873,253 $83.9 286
2024 Q4 21,174,653 $1,951,282,055 +$12,366,502 $92.14 305
2024 Q3 20,982,696 $1,948,703,180 +$24,926,468 $92.89 289
2024 Q2 20,545,327 $1,690,376,215 +$24,763,593 $82.28 261
2024 Q1 20,244,067 $1,343,284,255 +$11,987,251 $66.36 242
2023 Q4 20,084,131 $1,139,986,402 +$34,733,932 $56.76 226
2023 Q3 19,480,544 $1,061,371,614 +$32,738,721 $54.48 219
2023 Q2 18,811,526 $1,264,888,648 +$4,977,677 $67.28 208
2023 Q1 18,807,566 $968,037,117 -$3,487,147 $51.47 182
2022 Q4 19,244,139 $885,480,684 -$14,154,139 $46.02 181
2022 Q3 19,520,595 $989,204,894 -$6,064,140 $50.68 183
2022 Q2 19,290,567 $878,994,108 +$29,245,065 $45.55 175
2022 Q1 18,775,944 $872,420,057 +$20,477,763 $46.47 175
2021 Q4 18,437,180 $924,595,207 -$12,946,176 $50.23 178
2021 Q3 18,624,446 $989,044,311 +$47,360,392 $53.09 190
2021 Q2 17,706,224 $1,079,385,907 -$8,059,152 $61.02 183
2021 Q1 17,933,078 $875,505,917 +$19,714,714 $48.78 176
2020 Q4 17,703,794 $717,764,963 +$18,469,809 $40.5 168
2020 Q3 17,300,958 $562,850,201 +$13,819,279 $32.53 136
2020 Q2 16,847,952 $444,929,145 +$3,973,486 $26.4 141
2020 Q1 16,762,310 $417,910,467 -$43,457,877 $24.92 137
2019 Q4 17,302,384 $621,982,984 +$53,863,207 $35.95 158
2019 Q3 15,800,432 $540,055,367 +$12,879,648 $34.18 144
2019 Q2 15,502,902 $433,878,019 +$11,708,308 $27.98 146
2019 Q1 15,094,658 $467,913,143 +$5,913,399 $31 147
2018 Q4 15,028,286 $355,216,642 -$34,540,813 $23.64 136
2018 Q3 15,895,861 $615,732,972 +$21,851,073 $38.74 148
2018 Q2 15,431,749 $516,844,608 +$43,655,803 $33.48 159
2018 Q1 14,110,923 $511,463,797 +$11,850,444 $36.23 152
2017 Q4 14,068,048 $448,128,778 +$17,278,492 $31.84 138
2017 Q3 13,383,046 $500,651,805 +$30,975,265 $37.42 146
2017 Q2 12,630,436 $394,298,623 +$31,152,102 $31.22 141
2017 Q1 11,695,921 $288,085,788 +$40,290,492 $24.63 113
2016 Q4 11,172,728 $283,093,485 -$284,703 $25.34 111
2016 Q3 11,333,706 $224,855,790 +$6,582,634 $19.84 107
2016 Q2 11,052,641 $157,719,884 +$5,105,142 $14.27 97
2016 Q1 10,695,804 $165,991,000 +$7,840,540 $15.52 94
2015 Q4 10,165,288 $175,379,131 +$4,609,713 $17.25 91
2015 Q3 10,165,221 $123,905,280 +$4,272,693 $12.19 84
2015 Q2 9,412,740 $113,516,982 +$9,660,518 $12.06 75
2015 Q1 8,372,852 $70,163,000 +$1,710,724 $8.38 47
2014 Q4 8,171,831 $62,515,000 +$2,242,295 $7.65 44
2014 Q3 7,399,594 $50,911,000 -$284,391 $6.88 39
2014 Q2 7,437,668 $61,512,143 +$10,678,650 $8.27 40
2014 Q1 6,132,210 $49,464,700 +$886,602 $8.07 43